Get 30% off on our Global Market Reports with code ONLINE30 – Hurry, limited time offer!

What Are the Key Milestones in the Sepsis Diagnostics Market’s Growth Trajectory From 2025 To 2034?

The size of the sepsis diagnostics market has seen robust growth in the past few years. It is projected to expand from a market value of $0.99 billion in 2024 to $1.07 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. Factors responsible for this growth during the historical period include an elevated number of sepsis cases, heightened early diagnosis awareness, increased spending on healthcare, a growing number of hospital-acquired infections, and a rise in the uptake of point-of-care testing.

In the projected few years, the sepsis diagnostics market size is anticipated to witness substantial growth. By 2029, it is predicted to escalate to $1.47 billion with an 8.2% compound annual growth rate (CAGR). The upswing in this period is likely due to the heightened need for swift diagnostics, growing investments in healthcare infrastructure, an amplified emphasis on personalized medicine, an increase in antimicrobial resistance, and an escalating utilization of next-generation sequencing. Major trends projected for this period comprise the incorporation of AI in diagnostics, technological progress in biomarkers, developments in molecular diagnostics, transition towards mechanized and digital diagnostic platforms, and progress in the application of artificial intelligence in diagnostics.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23514&type=smp

What Are the Core Market Drivers Propelling Growth in the Sepsis Diagnostics Industry?

The surge in hospital-acquired infections is predicted to stimulate the expansion of the sepsis diagnostics market. These infections, also known as hospital-acquired infections (HAIs), occur during or after a patient’s stay in a medical facility, typically starting 48 hours or more post-admission, and were not present upon admission. This increase is attributed to the growth in antibiotic resistance, a consequence of overusing and improperly using antibiotics in healthcare environments, which encourages the evolution of resistant bacterial strains. This makes infections more challenging to manage. Sepsis diagnostics facilitates early detection of such infections by identifying pathogens and biomarkers, allowing for immediate treatment and reducing complications. For example, in November 2024, as per the Australian Institute of Health and Welfare, a government agency based in Australia, in the year 2022–23, it was noticed that 2% of public hospital and 0.8% of private hospital admissions had healthcare-associated infections, making it the most common complication. Thus, the surge in hospital-acquired infections is predicted to stimulate the sepsis diagnostics market’s growth.

How Is the Sepsis Diagnostics Market Segmented?

The sepsis diagnostics market covered in this report is segmented –

1) By Product: Instruments, Blood Culture Media, Assay Kits And Reagents, Software

2) By Technology: Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Other Technologies

3) By Pathogen: Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, Other Pathogens

4) By Method: Automated Diagnostics, Conventional Diagnostics

5) By End-Users: Hospitals And Clinics, Pathology And Reference Laboratories, Research Institutes

Subsegments:

1) By Instruments: Automated Analyzers, Point-Of-Care (PoC) Testing Devices, Microfluidic-Based Devices, Polymerase Chain Reaction (PCR) Instruments, Flow Cytometers

2) By Blood Culture Media: Aerobic Blood Culture Media, Anaerobic Blood Culture Media, Mycobacteria Blood Culture Media, Pediatric Blood Culture Media, Fungal Blood Culture Media

3) By Assay Kits And Reagents: Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Polymerase Chain Reaction (PCR) Assay Kits, Immunoassay Reagents, Molecular Diagnostic Reagents, Biosensor-Based Assay Kits

4) By Software: Data Management Software, Laboratory Information Systems (LIS), Artificial Intelligence (AI)-Based Diagnostic Tools, Predictive Analytics Software, Cloud-Based Diagnostic Platforms

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=23514&type=smp

Which Regions Are Driving the Next Phase of the Sepsis Diagnostics Market Growth?

North America was the largest region in the sepsis diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Sepsis Diagnostics Industry Evolution?

The sepsis diagnostics market is seeing main players pay attention to the creation of ground-breaking solutions, like those which do not require culture-based diagnostics, in an effort to promptly and accurately identify instances of sepsis without the need for traditional blood culture techniques. Methods of pathogen or infection detection not requiring conventional microbial culture approaches, known as culture-free diagnostic solutions, are being utilized. They hinge on cutting-edge technologies such as PCR (polymerase chain reaction), NGS (next-generation sequencing), or immunoassays as a means of speeding up the process of pathogen identification right from patient-derived samples like blood, saliva, or tissue. For example, Deepull Diagnostics S.L., a manufacturing firm based in Spain, unrolled the UllCORE diagnostic system in April 2024 to help with early detection of sepsis. The UllCORE system is a desktop multiplex PCR platform, a creation of Deepull, intended for quick pathogen identification in instances of sepsis and other similar acute infections. The system, operating by extracting microbial DNA from a whole 8 mL blood sample, provides 50 results that can be reported within a span of one hour. It has the ability to detect 95% of the pathogens that cause sepsis, which includes bacteria, fungi, and antibiotic resistance genes. With the goal of improving early diagnosis and curbing the misuse of antibiotics, UllCORE offers support to hospitals in their fight against antimicrobial resistance.

View the full report here:

https://www.thebusinessresearchcompany.com/report/sepsis-diagnostics-global-market-report

How Is the Sepsis Diagnostics Market Defined and What Are Its Core Parameters?

Sepsis diagnostics refers to a range of advanced technologies and tests designed to quickly detect the presence of sepsis, a critical condition that can lead to organ failure and death if left untreated. These technologies enable healthcare providers to assess the severity of the condition and make timely, informed decisions to initiate appropriate treatment and improve patient survival rates.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23514

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model